CliffBio
small molecule

ONTRALFY

TIZANIDINE HYDROCHLORIDE

Loss of exclusivityMay 2042latest FDA-listed patent expiry
CompanyFIDELITY BIOPHARMA CO USA

Drug detail

Brand nameONTRALFY
Active ingredientTIZANIDINE HYDROCHLORIDE
StrengthEQ 2MG BASE/5ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalDecember 2024
Marketing statusRX

Listed patents

PatentExpiresType
12263158May 2042product
12042484May 2042product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.